/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-04-18-09-16-42-370-6620e4fa7330266071d4ac1d.jpg)
Impressive advancements in the pharma industry provide hope to patients affected by debilitating and life-threatening diseases and a...
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-03-22-13-55-30-181-65fd8dd2c204230f6ea5c839.jpg)
In the much reported Illumina / Grail case, the European Commission (“Commission”) relied on Article 22 of the EU Merger Regulation...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-01-29-17-25-18-364-65b7df7e02736cec2cb77c05.jpg)
On 26 January 2024, the European Commission published a report providing an overview of the enforcement of EU antitrust and merger rules...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-11-06-16-13-22-681-654910a2b73e4823d3f16e7a.jpg)
On 12 October 2023, EU Foreign Subsidies Regulation (“FSR”) filings to the European Commission (“EC”) became mandatory. In addition to...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-05-29-16-50-42-903-6474d7e2473d2835c1506ef7.jpg)
On 23 May 2023, Joost Haans from our Life Sciences team attended the EU Pharma Law Forum in Brussels where he participated in the...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-10-21-13-55-49-885-6352a4e5f636ea1590d842b3.jpg)
Yesterday (20 October 2022), Advocate General (AG) Kokott of the European Court of Justice issued her Opinion in relation to the appeal...
